Assessment of lung glucose uptake in patients with systemic lupus erythematosus pulmonary arterial hypertension: a quantitative FDG-PET imaging study

L Wang, C Xiong, M Li, X Zeng, Q Wang… - Annals of Nuclear …, 2020 - Springer
Purpose Pulmonary arterial hypertension (PAH) is a recognized complication of systemic
lupus erythematosus (SLE-PAH) patients and its lung pathology shares similarity to …

Evaluation of lung glucose uptake with fluorine-18 fluorodeoxyglucose positron emission tomography/CT in patients with pulmonary arterial hypertension and …

H Ohira, R deKemp, Y Kadoya, J Renaud… - Annals of nuclear …, 2022 - jstage.jst.go.jp
Aim: Previous studies have demonstrated increased glucose uptake by 18 F-
fluorodeoxyglucose positron emission tomography (FDG-PET) in lung parenchyma in …

(18) F‐fluorodeoxyglucose uptake by positron emission tomography in patients with IPAH and CTEPH

C Sumer, G Okumus, EG Isik, C Turkmen… - Pulmonary …, 2024 - Wiley Online Library
Pulmonary arterial hypertension (PAH) is driven by pathologies associated with increased
metabolism such as pulmonary revascularization, vasoconstriction and smooth muscle cell …

18FDG PET Imaging can Quantify Increased Cellular Metabolism in Pulmonary Arterial Hypertension: A Proof-of-Principle Study

G Hagan, M Southwood, C Treacy… - Pulmonary …, 2011 - journals.sagepub.com
The past decade has seen increased application of 18-flurodeoxyglucose positron emission
tomography (18FDG-PET) imaging to help diagnose and monitor disease, particularly in …

Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension

MM Can, C Kaymaz, IH Tanboga… - Clinical nuclear …, 2011 - journals.lww.com
Methods: The study group comprised 23 patients with PAH and 16 healthy controls who
underwent FDG positron emission tomography. The ratio of RV uptake (u) of FDG to those of …

Heterogeneity in Lung 18FDG Uptake in Pulmonary Arterial Hypertension: Potential of Dynamic 18FDG Positron Emission Tomography With Kinetic Analysis as a …

L Zhao, A Ashek, L Wang, W Fang, S Dabral… - Circulation, 2013 - Am Heart Assoc
Background—Pulmonary arterial hypertension (PAH) is a disease of progressive vascular
remodeling, characterized by dysregulated growth of pulmonary vascular cells and …

The prognostic value of 18F-FDG uptake ratio between the right and left ventricles in idiopathic pulmonary arterial hypertension

W Li, L Wang, CM Xiong, T Yang, Y Zhang… - Clinical Nuclear …, 2015 - journals.lww.com
Purpose Metabolic changes occur in the right ventricle (RV) under increased afterload in
pulmonary arterial hypertension. FDG PET imaging has potential to assess RV function. In …

Quantitative assessment of right ventricular glucose metabolism in idiopathic pulmonary arterial hypertension patients: a longitudinal study

L Wang, W Li, Y Yang, W Wu, Q Cai… - European Heart …, 2016 - academic.oup.com
Aims Right ventricular (RV) glucose metabolism disorder in pulmonary arterial hypertension
(PAH) has been studied using 18F-fluorodeoxyglucose positron emission tomography (FDG …

Lung 18F-Fluorodeoxyglucose Positron Emission Tomography for Diagnosis and Monitoring of Pulmonary Arterial Hypertension

G Marsboom, C Wietholt, CR Haney… - American journal of …, 2012 - atsjournals.org
Rationale: Pulmonary arterial hypertension (PAH) is a proliferative arteriopathy associated
with glucose transporter-1 (Glut1) up-regulation and a glycolytic shift in lung metabolism …

Pulmonary 2-Deoxy-2-[18F]-Fluoro-D-Glucose Uptake is Low in Treated Patients with Idiopathic Pulmonary Arterial Hypertension

G Ruiter, YY Wong, P Raijmakers… - Pulmonary …, 2013 - journals.sagepub.com
Glucose metabolism measurement using 2-deoxy-2-[18F]-fluoro-D-glucose (18FDG)
positron emission tomography (PET) could provide in vivo information about pulmonary …